35644 Federal Register / Vol. 83, No. 145 / Friday, July 27, 2018 / Notices 

EARLY TERMINATIONS GRANTED—JUNE 1, 2018 THRU JUNE 30, 2018—Continued 

20181453 ...... G Elliott International Limited; Sempra Energy; Elliott International Limited. 

20181455 ...... G JSW Energy Interests LP; Sempra Energy; JSW Energy Interests LP. 

06/29/2018 

20181211 ...... G American Well Corporation; Avizia, Inc.; American Well Corporation. 

FOR FURTHER INFORMATION CONTACT: 

Theresa Kingsberry, Program Support 

Specialist, Federal Trade Commission 

Premerger Notification Office, Bureau of 

Competition, Room CC–5301, 

Washington, DC 20024, (202) 326–3100. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2018–16025 Filed 7–26–18; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control (BSC, NCIPC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of closed meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control (BSC, NCIPC). 

DATES: The meeting will be held on 

August 14, 2018, 1:00 p.m. to 3:00 p.m., 

EDT (CLOSED). 

ADDRESSES: Teleconference. 

FOR FURTHER INFORMATION CONTACT: 

Gwendolyn H. Cattledge, Ph.D., 

M.S.E.H., Deputy Associate Director for 

Science, NCIPC, CDC, 4770 Buford 

Highway NE, Mailstop F–63, Atlanta, 

GA 30341, Telephone (770) 488–1430, 

Email address: NCIPCBSC@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

meeting will be closed to the public in 

accordance with provisions set forth in 

Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the 

Director, Management Analysis and 

Services Office, CDC, pursuant to Public 

Law 92–463. 

Purpose: The Board of Scientific 

Counselors makes recommendations 

regarding policies, strategies, objectives, 

and priorities; and reviews progress 

toward injury prevention goals and 

provides evidence in injury preventionrelated research and programs. The 

Board also provides advice on the 

appropriate balance of intramural and 

extramural research, the structure, 

progress and performance of intramural 

programs. The Board is designed to 

provide guidance on extramural 

scientific program matters, including 

the: (1) Review of extramural research 

concepts for funding opportunity 

announcements; (2) conduct of 

Secondary Peer Review of extramural 

research grants, cooperative agreements, 

and contracts applications received in 

response to the funding opportunity 

announcements as it relates to the 

Center’s programmatic balance and 

mission; (3) submission of secondary 

review recommendations to the Center 

Director of applications to be considered 

for funding support; (4) review of 

research portfolios, and (5) review of 

program proposals. 

Matters To Be Considered: The agenda 

will include discussions on Secondary 

Peer Review of extramural research 

grant and cooperative agreement 

applications received in response to one 

(1) Notice of Funding Opportunity 

(NOFO): RFA–CE–18–006, Research 

Grants for Primary or Secondary 

Prevention of Opioid Overdose (RO1). 

Agenda items are subject to change as 

priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dia Taylor, 

Acting Chief Operating Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2018–16101 Filed 7–26–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), ICD–10 Coordination and 

Maintenance (C&M) Committee 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The CDC, National Center for 

Health Statistics (NCHS), Classifications 

and Public Health Data Standards Staff, 

announces the following meeting of the 

ICD–10 Coordination and Maintenance 

(C&M) Committee meeting. This 

meeting is open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 240 

people. We will be broadcasting the 

meeting live via Webcast at hhtp://

www.cms.gov/live/. 

DATES: The meeting will be held on 

September 11, 2018, 9:00 a.m. to 5:00 

p.m. EDT and September 12, 2018, 9:00 

a.m. to 5:00 p.m. EDT. 

ADDRESSES: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland 21244. 

FOR FURTHER INFORMATION CONTACT: 

Traci Ramirez, Program Specialist, CDC, 

3311 Toledo Rd., Hyattsville, MD 20782 

telephone (301) 458–4454; email 

address TRamirez@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The ICD–10 Coordination 

and Maintenance (C&M) Committee is a 

public forum for the presentation of 

proposed modifications to the 

International Classification of Diseases, 

Tenth Revision, Clinical Modification 

and ICD–10 Procedure Coding System. 

Matters To Be Considered: The agenda 

will include discussions on ICD–10– 

PCS Topics: 

Intraoperative Fluorescence Vascular 

Angiography for Lymphatic Mapping 

in Cervical and Uterine Cancers 

Insertion of Intramedullary Nail Limb 

Lengthening System 

Cell Suspension Autografting—REPEAT 

Subcutaneous Implantable Defibrillator 

System 


amozie on DSK3GDR082PROD with NOTICES1